Impact BioMedical Inc.
IBO | AMEX
$4.07
+$0.27 (+7.11%)
Nov 2, 2026, 12:14 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 32K | n/a | n/a | 50K | 50K | n/a |
Cost of Revenue | 424K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -392K | n/a | n/a | 50K | 50K | n/a |
Operating Income | -4.27M | -28.75M | -4.03M | -3.4M | -3.4M | -896.73K |
Interest Income | 13K | 3.95K | 13K | 24K | 165K | n/a |
Pretax Income | -14.45M | -24.74M | -4.41M | -7.88M | -7.88M | -896.73K |
Net Income | -11.84M | -24.71M | -4.34M | -7.05M | -7.05M | -597.34K |
Selling & General & Admin | 1.98M | 1.83M | 1.1M | 1.05M | 1.05M | 383.03K |
Research & Development | 340K | 278K | 1.69M | 1.23M | 1.23M | 513.69K |
Other Expenses | 1.56M | 26.65M | 1.24M | 1.18M | 1.18M | n/a |
Operating Expenses | 3.88M | 28.75M | 4.03M | 3.45M | 3.45M | 896.73K |
Interest Expense | 793K | 117.4K | 444K | 462K | 300K | n/a |
Selling & Marketing Expenses | 24K | 633K | 65K | n/a | n/a | n/a |
Cost & Expenses | 4.3M | 28.75M | 4.03M | 3.45M | 3.45M | 896.73K |
Income Tax Expense | -2.58M | 33K | n/a | -621K | -621K | -82K |
Shares Outstanding (Basic) | 2.5M | 3.31M | 4.77M | 911.07K | 911.07K | 911.57K |
Shares Outstanding (Diluted) | 2.5M | 3.31M | 4.77M | 911.07K | 911.57K | 911.57K |
EPS (Basic) | -4.80 | -0.09 | -0.88 | -7.70 | -7.70 | -0.65 |
EPS (Diluted) | -4.80 | -0.09 | -0.88 | -7.70 | -7.70 | -0.65 |
EBITDA | -12.51M | -22.55M | -2.84M | -6.3M | -6.3M | -896.73K |
EBIT | -13.66M | -23.67M | -3.96M | -7.41M | -7.41M | -896.73K |
Depreciation & Amortization | 1.15M | 1.12M | 1.12M | 1.11M | 1.11M | n/a |
Add to Watchlist
Select watchlists to add or remove IBO